HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of Germline MEFV Polymorphisms on the Prognosis of Japanese Children with Cancer: A Regional Analysis.

AbstractINTRODUCTION:
MEFV is the gene responsible for familial Mediterranean fever. It encodes pyrin, which controls inflammation. Besides, previous studies have reported that some germline MEFV variants were associated with tumour susceptibility.
MATERIALS AND METHODS:
The loci of 12 germline MEFV variants were genotyped in 153 Japanese children with cancer, and the frequencies of these variants among the patient groups were compared with those in the general Japanese population. Additionally, the relationship between these variants and clinical data, including relapse and death, was investigated.
RESULTS:
Minor allele frequencies did not differ between patients and the general population, or between sex, age at diagnosis, and diagnosis among patients. P369S/R408Q associated with significantly lower relapse-free survival in all patient analyses and in patients with solid tumours. Additionally, although the results were not significant, E148Q/L110P was likely to associate with worse relapse-free survival in patients with solid tumours.
DISCUSSION/CONCLUSION:
Despite several limitations, this study provided the novel insight that the germline MEFV variants are associated with the clinical outcome of paediatric cancer.
AuthorsMorio Hasegawa, Hiroko Fukushima, Ryoko Suzuki, Yuni Yamaki, Sho Hosaka, Masako Inaba, Tomohei Nakao, Chie Kobayashi, Ai Yoshimi, Masahiro Tsuchida, Kazutoshi Koike, Takashi Fukushima, Hidetoshi Takada
JournalOncology (Oncology) Vol. 100 Issue 7 Pg. 376-383 ( 2022) ISSN: 1423-0232 [Electronic] Switzerland
PMID35551132 (Publication Type: Journal Article)
Copyright© 2022 S. Karger AG, Basel.
Chemical References
  • Cytoskeletal Proteins
  • MEFV protein, human
  • Pyrin
Topics
  • Child
  • Cytoskeletal Proteins (genetics)
  • Genetic Predisposition to Disease
  • Germ Cells
  • Humans
  • Japan (epidemiology)
  • Mutation
  • Neoplasms (genetics)
  • Prognosis
  • Pyrin (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: